Scientific Committee
Title:
Eliminating Cancer Return with Nanomedicine: Human Clinical TrialsBiography
Thomas J. Webster’s (H index: 137) degrees are in chemical engineering from the University of Pittsburgh (B.S., 1995; USA) and in biomedical engineering from RPI (Ph.D., 2000; USA). He has formed over a dozen companies who have numerous FDA approved medical products currently improving human health in over 45,000 patients. He is currently helping those companies and serves as a professor at Brown University, Saveetha University, Hebei University of Technology, UFPI, University of the Basque Country, and others. Dr. Webster has numerous awards including: 2020, World Top 2% Scientist by Citations (PLOS); 2020, SCOPUS Highly Cited Research (Top 1% Materials Science and Mixed Fields); 2021, Clarivate Top 0.1% Most Influential Researchers (Pharmacology and Toxicology); 2022, Best Materials Science Scientist by Citations (Research.com); and is a fellow of over 8 societies. Prof. Webster is a former President of the U.S. Society for Biomaterials and has over 1,350 publications to his credit with over 55,000 citations. He was recently nominated for the Nobel Prize in Chemistry. Prof. Webster also recently formed a fund to support Nigerian student research opportunities in the U.S
Abstract
This presentation will cover a close to 30 year journey researching and commercializing nanotechnology for improving disease prevention, diagnosis, and treatment (including cancer) which has led to numerous products including nano spinal implants now in over 45,000 patients to date showing no signs of failure according to the FDA MAUDE database. Traditional orthopedic implants face a failure rate of 5 – 10% and sometimes as high as 60% for bone cancer patients. The talk will cover not only human clinical evidence of the unprecedented efficacy of nanotechnology in medicine but also fundamental evidence of how nanotechnology can be used clinically to kill cancer cells, bacteria, inhibit inflammation, and promote tissue growth (if needed) without drugs. This talk will also describe the future of nanotechnology and how it will in the not too distant future combat traditional failures in our global healthcare system including reversing the current decrease in global average life expectancy, creating a reactive compared to predictive healthcare system, transforming a healthcare system that relies too much on drugs and pharmaceutical agents to treat ailments, facilitating a non-personalized healthcare system, combating increasing costs, treating a growing global population, and more through the future use of implantable nano sensors, 4D printed nano materials, smart nano materials, environmentally-friendly nanomaterials, and AI as well as other predictive models in medicine and more.
